Kenya Ophthalmology Market Analysis


  • Type: Therapeutics Area
  • Published : June 2021
  • Region: Africa
  • Country: Kenya
  • Report ID : 4825

  • Format: PPT, PDF

Kenya Ophthalmic Diseases Drugs Market: Segmented by Disease types (Refractive Errors, Trachoma, Glaucoma, Cataract, Diabetic Retinopathy, Age-Related Macular Degeneration, Allergic Conjunctivitis), Drug Class (Anti-Allergic, Corticosteroids, Non-Steroidal Anti-Inflammatory Drugs, Anti-Biotics, Anti-Glaucoma, and Other Drug Classes), Route of Administration (Oral, Topical and Other), Mode of Prescription (Prescription-Based Drugs, OTC Drugs) and Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online and Others) – Growth, Trends, and Forecasts (2019 – 2028)

SKU: 4825 Categories: ,

Report Overview

The Ophthalmic diseases drugs market size in Kenya stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

According to the National Eye Health Strategy Plan by the Ministry of Health, an estimated 15.5% of Kenyans are in need of quality eye care services, ranging from cataract surgery, diabetic retinopathy care, spectacle corrections and even basic ocular allergy treatment. About 0.7% of all rural Kenyans are blind in their better eye, and another 2.5% have vision which is substantially impaired. In Kenya it is estimated that 4.3% of persons aged above 50 years have the glaucoma disease and cataract contributes almost half (43%) of the total blindness, and 35.9% of the total population have Diabetes Mellitus with Diabetic Retinopathy. Cataract and Glaucoma impact negatively on the quality of life and may influence daily activities such as driving, walking and economic activities. Hence the ophthalmic diseases Drugs market in Kenya will experience enormous growth during the forecasted period.

Market Drivers

The market is majorly driven by the rising prevalence of ophthalmic diseases in Kenya. According to a study, the prevalence of visual impairment was 2.4% among the children aged 0-5 years in Kenya.

The Ophthalmic Division in Kenya has improved the health care and enhanced public awareness on ocular conditions such as refractive error. This has aided in early detection of ocular diseases and management making patients to regain their sight at an early age. The study conducted in Kenya, Nakuru County, estimated that 92,000 adults aged ≥50 years had visual impairment of whom 11,600 were blind, out of a total population of approximately 4.3 million.

The increasing incidence of Ophthalmic diseases and increasing levels of awareness-related to Ophthalmic disease and treatments available are leading to a high growth of Ophthalmic Drugs.

Increase in the effective delivery of eye health care services and appropriate infrastructure for screening and detection of ophthalmic diseases will propel growth in the ophthalmic diseases therapeutic market during the forecasted period.

However, limited number of trained optometrists and human resources hamper growth of the ophthalmic disease Drugs market. Uncertain reimbursement policy is restraining market’s growth.

1. Kenya Ophthalmic Diseases Drugs Market Overview…………………………….
A. Market Size
2. Market Growth Drivers………………………………………………………….
A. Rise in Prevalence of Ophthalmic Diseases like Glaucoma and Trachoma
B. Increase in Appropriate Eye Health Infrastructure and Effective Delivery of Eye Health Care Services.
3. Major Ophthalmic Diseases …………………………………………………………
A. Refractive Errors
B. Trachoma
C. Glaucoma
D. Cataract
E. Diabetic Retinopathy
F. Age-Related Macular Regeneration
G. Allergic Conjunctivitis
H. Others
4. Ophthalmic Diseases Drugs Market Segmentation……………………………….
A. Drug Class
I. Anti-Allergic
II. Corticosteroids
III. Anti-Biotics
IV. Anti-Glaucoma
V. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
VI. Others
B. Route of Administration
I. Oral
II. Topical
III. Other
C. Mode of Prescription
I. Prescription-Based Drugs
II. Over-The-Counter Drugs
D. Distribution Channels
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online
IV. Others
5. Ophthalmic Diseases Major Products Market Share………………………….
A. Key Findings
B. Market Analysis, Insights and Forecast – By Drug Type
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………
A. GlaxoSmithKline Company overview, Product & Services, Strategies & Financials
B. Company overview, Product & Services, Strategies & Financials
C. Novartis Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………
A. New Trends and Development of Ophthalmic drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Indication:

On the basis of Indication, the ophthalmic disease Drugs market can be segmented into refractive errors, trachoma, glaucoma, cataract, diabetic retinopathy, allergic conjunctivitis and age-related macular degeneration.

Trachoma is a bacterial eye disease caused by Chlamydia trachomatis. Glaucoma is a group of eye conditions that damages the optic nerve. Cataract refers to clouding of the lens of the eye due to deposition of proteins. Allergic Conjunctivitis is inflammation of the lining of the eye due to allergens like pollen etc.

By Drug Class:

On the basis of drug class, the ophthalmic disease Drugs market in Kenya can be segmented into anti-allergic, corticosteroids, non-steroidal anti-inflammatory drugs, anti-biotics, anti-glaucoma and other drug classes.

By Route of Administration:

On the basis of route of administration, the market can be segmented into oral, topical and other drugs.

Topical drugs segment accounts for the largest market share and it includes eye drops, eye gels, ointments and solutions.

By Mode of Prescription:

On the basis of mode of prescription, the market can be segmented into prescription-based drugs and over-the-counter drugs.

The fastest growing segment is the over-the-counter drugs segment during the forecasted period.

By Distribution Channels:

On the basis of distribution channels, the market can be segmented into hospital pharmacies, retail pharmacies, online pharmacies and others.

Major Players

Prominent companies leading in the ophthalmic disease therapeutic market are Bayer East Africa Limited, GlaxoSmithKline (GSK),, Novartis, Eli Lilly, Roche and Novo Nordisk. Many new players are entering the market owing to high growth opportunities.

Some of the local pharmaceutical companies in Kenya operating in the ophthalmic drug market are Cosmos Limited, Alpha Medical Manufacturers and Universal Pharmaceutical Limited.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements